MedTrace Logo

Nerve Block Vs Sedation Infusion for Awake Fiberoptic Intubation.

NCT06651905 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2024-10-23

No results posted yet for this study

Summary

This study compares the efficacy and safety of dexmedetomidine infusion versus superior laryngeal nerve block during awake fiberoptic intubation in hemimandibulectomy patients.

Conditions

  • Superior Laryngeal Nerve Block
  • Sedation
  • Dexmedetomidine
  • Awake Fiberoptic Intubation
  • Hemimandibulectomy
  • Anticipated Difficult Airway

Interventions

DRUG

Dexmedetomidine

The patients were given 0.5 mcg /kg dexmedetomidine over 10 min via syringe pump, followed by 0.2-0.7 mcg/kg/hour until the end of intubation according to hemodynamics.

DRUG

Superior laryngeal nerve block

The patients received an airway nerve block through bilateral superior laryngeal nerve block and trans-tracheal injection for recurrent laryngeal nerve.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Tarek Abd EL Halim Kaddah, MD · Professor

  • Mai M EL Rawas, MD · Lecturer

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2024-09-01
Completion
2024-09-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06651905 on ClinicalTrials.gov